Abstract: The present invention relates to a gel composition comprising a glucan and a gelling agent, said composition having a melting point (gel to sol) above 37° C., as well as to the uses of this composition in therapy, in particular in wound healing.
Type:
Grant
Filed:
November 29, 2011
Date of Patent:
May 1, 2018
Assignee:
BIOTECH PHARMACON ASA
Inventors:
Rolf Engstad, Dag-Eirik Ramsøy, Erik Steene
Abstract: A method of increasing immunostimulation in animals by administering to the animal a glucan product comprising a branched ?-(1,3) glucan with ?-(1,3)-linked side chains being attached by a ?-(1,6)-linkage and being essentially free of side chains containing more than four ?-(1,6)-bound glucose units.
Type:
Grant
Filed:
March 30, 2005
Date of Patent:
February 8, 2011
Assignee:
Biotech Pharmacon ASA
Inventors:
Rolf Engstad, Finn Kortner, Borre Robertsen, Gunnar Rorstad